Find your next paid study

Duke UniversityNCT06875206

Actual pay is set by the research site.

Advanced Heart FailureAdvanced Non-Colorectal Gastointestinal CancerAdvanced Lung Cancer

TIER-PALLIATIVE CARE: A Population-based Care Delivery Model to Match Evolving Patient Needs and Palliative Care Services for Community-based Patients With Heart Failure or Cancer

TIER-PC is an adaptive model of delivering palliative care that provides the right level of care to the right patients at the right time. It represents an adap…

Icahn School of Medicine at Mount SinaiNCT06228209

Actual pay is set by the research site.

Depression in AdolescenceSuicide Prevention

Strategic Treatment Assessment With Youth (STAY): A Measurement-based Care Approach to Promote Treatment Retention Among Racial and Ethnic Minoritized Youth With Depression or Suicide Risk

This multi-method, multi-phase pilot trial is designed to explore initial implementation and effectiveness of a theoretically-driven, culturally-tailored, meas…

Yale UniversityNCT06515236

Actual pay is set by the research site.

Intensive Multi-Disciplinary Care Initiative for Patients With Newly Diagnosed Brain Metastases

This is a health services intervention study aimed at understanding the impact of intensive multi-disciplinary care compared with standard care on patient-repo…

Brain Metastases, Adult

University of Vermont Medical CenterNCT06280300

Actual pay is set by the research site.

Exploration of Novel AI-enabled Blue Light Enhanced Cystoscopy

Blue light cystoscopy (BLC) is a diagnostic procedure in bladder cancer where the inside of the bladder is observed with a camera to detect bladder lesions. Un…

Bladder CancerNon-muscle Invasive Bladder Cancer

Locally Advanced Bladder Urothelial CarcinomaLocally Advanced Renal Pelvis and Ureter Urothelial CarcinomaMetastatic Bladder Urothelial Carcinoma+4 more

~$10 – $1,125

Actual pay is set by the research site.

PhotocureNCT07144319

Phase 4

CAST-AI: Cystectomy After Systemic Therapy With ADC and Immunotherapy

This phase IV trial tests the impact of standard of care enfortumab vedotin and pembrolizumab followed by removal of all or part of the bladder (cytoreductive …

Distal Radius Fracture ReductionPain ControlPediatric Fractures

~$25 – $1,000

Actual pay is set by the research site.

Mayo ClinicNCT06764095

Phase 3

Pain Control Alternatives in Pediatric Patients With Distal Radius Fractures

The aim of this study is to evaluate the efficacy of a hematoma block and minimal ketamine pain control or hematoma block and intranasal fentanyl in pediatric …

State University of New York at BuffaloNCT07120763

~$50 – $1,500

Actual pay is set by the research site.

Hepatocellular CarcinomaRadiation Exposure

Y90 Radioembolization Dose Delivery and Radiation Exposure Assessment

The objective of this study is to examine critical aspects of radiation exposure, dose delivery, and systemic yttrium-90 (Y90) exposure related to the infusion…

University of TennesseeNCT03686709

Actual pay is set by the research site.

Biospecimen Procurement for the Study of Head and Neck Disorders

Background: Researchers want to learn more about head and neck disorders. Understanding these disorders could help them find better treatments. To do this, th…

Hearing DisorderOral Mucosal DiseasePharyngeal Neoplasm+2 more

National Cancer Institute (NCI)NCT03429036

~$10 – $675

Actual pay is set by the research site.

Phase 1

NBTXR3 With Radiation Therapy Alone for Locally-advanced Non-small Cell Lung Cancer

This is a single institution, single arm phase I/II study of NBTXR3 with radiation therapy for stage I-III advanced non-small cell lung cancer patients who are…

Locally-Advanced Non-Small Cell Lung Cancer

M.D. Anderson Cancer CenterNCT07224152

~$150 – $3,000

Actual pay is set by the research site.

Phase 2

A Global, Multicenter, Randomized, Dose-Optimization Phase II Study of Trastuzumab Rezetecan (SHR-A1811) in Combination With mFOLFOX6 (-1) and Bevacizumab as First-Line Treatment in Patients With HER2-Positive Advanced Colorectal Cancer (HORIZON-CRC221)

This global study is being conducted to evaluate the safety and determine the recommended phase 3 dose of trastuzumab rezetecan in combination with mFOLFOX6 ch…

Advanced Colorectal Cancer Expressing HER2

Jiangsu HengRui Medicine Co., Ltd.NCT07796763

~$75 – $2,800

Actual pay is set by the research site.

Phase 1

Phase I Clinical Trial of Rituximab (Rtx) and Tafasitamab in Combination With Allogeneic NK Cells for Treatment of Relapsed/Refractory (r/r) B-cell Non-Hodgkin Lymphoma

This research study is for people who have relapsed or refractory B-cell non-Hodgkin's lymphoma (NHL) that has not responded to two or more lines of therapy. T…

Non Hodgkin LymphomaB-cell Non Hodgkin LymphomaDiffuse Large B Cell Lymphoma+7 more